MREO
Mereo BioPharma Group plcCompany with tickers: MREO
CIK
1719714
CUSIP
589492107
Shares Outstanding
159,618,609
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-26 | Jacquet Pierre | Director | Award | 66,000 |
| 2026-02-26 | Jacquet Pierre | Director | Award | 106,848 |
| 2026-02-26 | Yoskowitz Marc J | Director | Award | 66,000 |
| 2026-02-26 | Yoskowitz Marc J | Director | Award | 96,163 |
| 2026-02-26 | Shames Daniel | Director | Award | 96,163 |
| 2026-02-26 | Shames Daniel | Director | Award | 66,000 |
| 2026-02-26 | Ekblom Anders | Director | Award | 66,000 |
| 2026-02-26 | Ekblom Anders | Director | Award | 133,560 |
| 2026-02-26 | Bender Jeremy | Director | Award | 117,533 |
| 2026-02-26 | Bender Jeremy | Director | Award | 66,000 |
| 2026-02-26 | PAKIANATHAN DEEPIKA | Director | Award | 66,000 |
| 2026-02-26 | Jenkins Annalisa | Director | Award | 106,848 |
| 2026-02-26 | Jenkins Annalisa | Director | Award | 66,000 |
| 2026-02-26 | WYZGA MICHAEL S | Director | Award | 66,000 |
| 2026-02-01 | Lewicki John A. | Chief Scientific Officer | Award | 46,637 |
| 2026-02-01 | Lewicki John A. | Chief Scientific Officer | Award | 145,000 |
| 2026-02-01 | Lewicki John A. | Chief Scientific Officer | Award | 139,913 |
| 2026-02-01 | Sermon Charles | General Counsel | Award | 295,000 |
| 2026-02-01 | Sermon Charles | General Counsel | Award | 315,750 |
| 2026-02-01 | Hughes-Wilson Alexandra | See Remarks | Award | 183,750 |
| 2026-02-01 | Hughes-Wilson Alexandra | See Remarks | Award | 195,000 |
| 2026-02-01 | Hughes-Wilson Alexandra | See Remarks | Award | 61,250 |
| 2026-02-01 | Scots-Knight Denise | Director, Chief Executive Officer | Award | 1,035,000 |
| 2026-02-01 | Scots-Knight Denise | Director, Chief Executive Officer | Award | 480,000 |
| 2026-02-01 | Scots-Knight Denise | Director, Chief Executive Officer | Award | 345,000 |
| 2026-02-01 | Sermon Charles | General Counsel | Award | 105,250 |
| 2026-02-01 | Fox Christine Ann | Chief Financial Officer | Award | 105,250 |
| 2026-02-01 | Fox Christine Ann | Chief Financial Officer | Award | 280,000 |
| 2026-02-01 | Fox Christine Ann | Chief Financial Officer | Award | 315,750 |
| 2025-02-05 | Jacquet Pierre | Director | Award | 15,243 |
| 2025-02-05 | Jacquet Pierre | Director | Award | 55,000 |
| 2025-02-05 | Yoskowitz Marc J | Director | Award | 55,000 |
| 2025-02-05 | Yoskowitz Marc J | Director | Award | 13,719 |
| 2025-02-05 | Bender Jeremy | Director | Award | 16,768 |
| 2025-02-05 | Bender Jeremy | Director | Award | 55,000 |
| 2025-02-05 | Shames Daniel | Director | Award | 55,000 |
| 2025-02-05 | Shames Daniel | Director | Award | 13,719 |
| 2025-02-05 | Jenkins Annalisa | Director | Award | 55,000 |
| 2025-02-05 | PAKIANATHAN DEEPIKA | Director | Award | 55,000 |
| 2025-02-05 | Ekblom Anders | Director | Award | 19,054 |
| 2025-02-05 | Ekblom Anders | Director | Award | 55,000 |
| 2025-02-05 | WYZGA MICHAEL S | Director | Award | 30,487 |
| 2025-02-05 | WYZGA MICHAEL S | Director | Award | 55,000 |
| 2025-02-05 | Jenkins Annalisa | Director | Award | 15,243 |
| 2025-01-25 | Fox Christine Ann | Chief Financial Officer | Award | 262,000 |
| 2025-01-25 | Scots-Knight Denise | Director, Chief Executive Officer | Award | 825,000 |
| 2025-01-25 | Lewicki John A. | Chief Scientific Officer | Award | 116,000 |
| 2025-01-25 | Sermon Charles | General Counsel | Award | 262,000 |
| 2025-01-25 | Hughes-Wilson Alexandra | See Remarks | Award | 154,000 |
| 2024-09-13 | Lewicki John A. | Chief Scientific Officer | Sell | 10,937 |
| 2024-09-13 | Fox Christine Ann | Chief Financial Officer | Sell | 19,158 |
| 2024-09-13 | Scots-Knight Denise | Director, Chief Executive Officer | Sell | 60,046 |
| 2024-09-13 | Sermon Charles | General Counsel | Sell | 20,946 |
| 2024-09-13 | Hughes-Wilson Alexandra | See Remarks | Sell | 84,008 |
| 2024-09-13 | Hughes-Wilson Alexandra | See Remarks | Sell | 16,304 |
| 2024-09-12 | Lewicki John A. | Chief Scientific Officer | Other | 14,196 |
| 2024-09-12 | Lewicki John A. | Chief Scientific Officer | Sell | 5,212 |
| 2024-09-12 | Scots-Knight Denise | Director, Chief Executive Officer | Sell | 28,611 |
| 2024-09-12 | Sermon Charles | General Counsel | Sell | 9,980 |
| 2024-09-12 | Hughes-Wilson Alexandra | See Remarks | Sell | 7,769 |
| 2024-09-12 | Hughes-Wilson Alexandra | See Remarks | Sell | 40,029 |
| 2024-09-12 | Fox Christine Ann | Chief Financial Officer | Sell | 9,128 |
| 2024-09-11 | Fox Christine Ann | Chief Financial Officer | Convert | 60,000 |
| 2024-09-11 | Fox Christine Ann | Chief Financial Officer | Convert | 60,000 |
| 2024-09-11 | Lewicki John A. | Chief Scientific Officer | Convert | 46,000 |
| 2024-09-11 | Lewicki John A. | Chief Scientific Officer | Other | 14,196 |
| 2024-09-11 | Lewicki John A. | Chief Scientific Officer | Convert | 46,000 |
| 2024-09-11 | Sermon Charles | General Counsel | Convert | 65,600 |
| 2024-09-11 | Sermon Charles | General Counsel | Convert | 65,600 |
| 2024-09-11 | Scots-Knight Denise | Director, Chief Executive Officer | Convert | 188,060 |
| 2024-09-11 | Scots-Knight Denise | Director, Chief Executive Officer | Convert | 188,060 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 93,333 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 75,000 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 40,000 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 93,333 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 40,000 |
| 2024-09-11 | Hughes-Wilson Alexandra | See Remarks | Convert | 75,000 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 12,418 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 15,000 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 1,825 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Sell | 105,244 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 43,485 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 55,000 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 31,500 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 55,000 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 2,071 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 6,492 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 11,000 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 5,500 |
| 2024-08-22 | PAKIANATHAN DEEPIKA | Director | Convert | 38,953 |
| 2024-06-26 | Sermon Charles | General Counsel | Sell | 32,187 |
| 2024-06-26 | Lewicki John A. | Chief Scientific Officer | Sell | 16,808 |
| 2024-06-26 | Fox Christine Ann | Chief Financial Officer | Sell | 29,439 |
| 2024-06-26 | Scots-Knight Denise | Director, Chief Executive Officer | Sell | 92,273 |
| 2024-06-26 | Hughes-Wilson Alexandra | See Remarks | Sell | 22,968 |
| 2024-06-25 | Sermon Charles | General Counsel | Sell | 14,202 |
| 2024-06-25 | Lewicki John A. | Chief Scientific Officer | Other | 14,196 |
| 2024-06-25 | Lewicki John A. | Chief Scientific Officer | Sell | 7,416 |
| 2024-06-25 | Fox Christine Ann | Chief Financial Officer | Sell | 12,990 |
| 2024-06-25 | Scots-Knight Denise | Director, Chief Executive Officer | Sell | 40,712 |